---
layout: post
title: "Moonage Media Review: Clearmind's MEAI and GLP-1 - Are These the Next-Generation Treatment for Weight Loss?"
date: 2026-02-19T18:05:00+00:00
source: PR Newswire Releases
source_url: https://www.prnewswire.com/news-releases/moonage-media-review-clearminds-meai-and-glp-1---are-these-the-next-generation-treatment-for-weight-loss-302692780.html
significance: 8.00
---

<p>HONG KONG, Feb. 19, 2026 /PRNewswire/ -- As the multi-billion-dollar obesity treatment market continues to search for new therapeutic approaches beyond GLP-1â€“based treatments, Clearmind Medicine (Nasdaq: CMND), a clinical-stage biotech company focused on the discovery and development of...</p>

**Source:** [PR Newswire Releases](https://www.prnewswire.com/news-releases/moonage-media-review-clearminds-meai-and-glp-1---are-these-the-next-generation-treatment-for-weight-loss-302692780.html)

**Published:** 2026-02-19 18:05:00 +0000

**Significance Score:** 8.00

[View original](https://www.prnewswire.com/news-releases/moonage-media-review-clearminds-meai-and-glp-1---are-these-the-next-generation-treatment-for-weight-loss-302692780.html)
